4 assets in Craniopharyngioma

Therapeutic assets addressing Craniopharyngioma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
L-Methionine Craniopharyngioma	St. Jude Children's Research Hospital	P2	CCC (53)
Phentermine Craniopharyngioma	Seattle Children's Hospital	P2	CCC (53)
Topiramate Craniopharyngioma	Seattle Children's Hospital	P2	CCC (53)
Liraglutide Craniopharyngioma	Seoul National University Hospital	Early P1	C (39)